Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The United States isn’t alone in grappling with this growing health problem.
Researchers analyzed rates of use of buprenorphine, which is used to treat opioid use disorder, between 2009 and 2018.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
Taking opioids at the same time as benzodiazepines, such as Xanax and Ativan, is also associated with overdose.
The majority of new cases of hepatitis C occur among people younger than 30 who inject drugs.
An analysis of newly diagnosed youths in California found they had limited access to opioid-related harm reduction services.
It’s a lot easier to fight addiction when you have a stable place to live.
Researchers followed a group of teenagers over time and found that their rate of non-alcoholic fatty liver disease rose in young adulthood.
Researchers analyzed data on more than a quarter of a million teens and young adults attending federally qualified health centers.
Doctors are finding ways to diagnose and treat this difficult-to-reach demographic.
Matt Heskett discusses his journey with hepatitis C for the first time with the press.
Researchers modeled the differences between testing focused on baby boomers versus universal screening.
Baby boomers still make up the largest bloc of those with the virus, but youths’ injection drug use is sending their infection rates upward.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.